Article
Molecular Mechanism of Tumor Progression and Novel Therapeutic and Diagnostic Strategies in Mesothelioma
2025-03-31
Abstract excerpt
Mesothelioma is characterized by the inactivation of tumor suppressor genes, with frequent mutations in neurofibromin 2 (NF2), BRCA1-associated protein 1 (BAP1), and cyclin-dependent kinase inhibitor 2A (CDKN2A). These mutations lead to disruptions in the Hippo signaling pathway and histone methylation, promoting tumor growth. NF2 mutations result in Merlin loss, leading to uncontrolled cell proliferation, whereas...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 05089302-a582-559e-a457-5be6f8a3cac5
- DOI
- 10.20944/preprints202503.2357.v1
